vidarabine has been researched along with Leukemia, Lymphocytic, Chronic, T Cell in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Beckerleg, W; Milman, N; van der Jagt, R | 1 |
| Anagnostopoulos, A; Chatzidimitriou, A; Galigalidou, C; Gemenetzi, K; Ghia, P; Ioannou, N; Iskas, M; Koravou, E; Kotouza, M; Kotta, K; Kouvatsi, A; Papazoglou, D; Pasentsis, K; Psomopoulos, F; Ramsay, AG; Scarfó, L; Stamatopoulos, K; Stavroyianni, N; Vardi, A; Vlachonikola, E | 1 |
| Bahlo, J; Cramer, P; Dürig, J; Eichhorst, B; Fink, AM; Hallek, M; Herling, M; Hopfinger, G; Kreuzer, KA; Mayer, P; Oberbeck, S; Pflug, N; Robrecht, S; Schrader, A; Seiler, T; Stilgenbauer, S; Westermann, A; Zenz, T | 1 |
| Busch, R; Cramer, P; Döhner, H; Eichhorst, B; Fingerle-Rowson, G; Fink, AM; Hallek, M; Herling, M; Hopfinger, G; Kandler, G; Pflug, N; Reinart, N; Stilgenbauer, S; Weit, N; Westermann, A; Winkler, D | 1 |
| Bayhan, T; Ceylaner, S; Demir, HA; Emir, S; Karakuş, E; Kurtulan, O; Özyörük, D; Üner, A | 1 |
| Jeong, KH; Lew, BL; Sim, WY | 1 |
| Arima, N; Niino, D; Ohshima, K; Tsuda, H; Tsuji, T; Yamasaki, H | 1 |
| Brettman, L; Cooper, MR; Freter, CE; Mercier, RJ; Mitchell, BS; Rai, KR; Santábarbara, P; Stadtmauer, EA; Wacker, B | 1 |
| Au, WY; Chim, CS; Kwong, YL; Lam, CC; Leung, AY; Liang, R; Lie, AK; Ma, SY; Tse, E | 1 |
| Gandhi, V; Jewell, RC; Keating, MJ; Lerner, S; O'Brien, S; Plunkett, W; Rodriguez, CO; Tam, C | 1 |
| Lundberg, JH; Tefferi, A; Weitz, JJ; Witzig, TE | 1 |
5 trial(s) available for vidarabine and Leukemia, Lymphocytic, Chronic, T Cell
| Article | Year |
|---|---|
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
Topics: Adult; Aged; Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Incidence; Induction Chemotherapy; Kaplan-Meier Estimate; Leukemia, Prolymphocytic, T-Cell; Maintenance Chemotherapy; Male; Middle Aged; Mitoxantrone; Treatment Outcome; Vidarabine | 2019 |
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Disease-Free Survival; Female; Humans; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Mitoxantrone; Proto-Oncogene Proteins; Remission Induction; Treatment Outcome; Vidarabine | 2013 |
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antimetabolites, Antineoplastic; Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic, T-Cell; Male; Neutropenia; Opportunistic Infections; Pilot Projects; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Failure; Treatment Outcome; Vidarabine | 2002 |
Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asian People; Dexamethasone; Disease-Free Survival; Female; Humans; Leukemia, Prolymphocytic, T-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vidarabine | 2004 |
Phase I trial of nelarabine in indolent leukemias.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleosides; Arabinonucleotides; DNA (Cytosine-5-)-Methyltransferases; Drug Therapy, Combination; Female; Guanosine Triphosphate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Tumor Cells, Cultured; Vidarabine | 2008 |
6 other study(ies) available for vidarabine and Leukemia, Lymphocytic, Chronic, T Cell
| Article | Year |
|---|---|
Systemic Large-Vessel Vasculitis and Retroperitoneal Fibrosis in the Setting of T-Cell Chronic Lymphocytic Leukemia: A Case Report.
Topics: Aged; Antineoplastic Agents; Aorta, Thoracic; Chest Pain; Computed Tomography Angiography; Coronary Vessels; Cyclophosphamide; Humans; Leukemia, Prolymphocytic, T-Cell; Lymphadenopathy; Male; Prednisone; Retroperitoneal Fibrosis; Systemic Vasculitis; Treatment Outcome; Vidarabine | 2020 |
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clonal Evolution; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Female; Humans; Immunological Synapses; Immunophenotyping; Leukemia, Prolymphocytic, T-Cell; Male; Middle Aged; Piperidines; Purines; Quinazolinones; Rituximab; T-Lymphocytes; Vidarabine | 2020 |
Chronic lymphocytic leukemia in a child: a challenging diagnosis in pediatric oncology practice.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Receptor Nuclear Translocator; Cyclophosphamide; Female; Gene Deletion; Humans; Leukemia, Prolymphocytic, T-Cell; Rituximab; Treatment Outcome; Vidarabine | 2014 |
Generalized leukaemia cutis from a small cell variant of T-cell prolymphocytic leukaemia presenting with exfoliative dermatitis.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Examination; Dermatitis, Exfoliative; Diagnostic Errors; Erythema; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Prolymphocytic, T-Cell; Leukemic Infiltration; Male; Prednisone; Skin; T-Lymphocytes; Treatment Failure; Vidarabine | 2009 |
Epstein-Barr virus-negative classical Hodgkin's lymphoma in a patient with T-cell prolymphocytic leukemia treated with fludarabine.
Topics: Antineoplastic Agents; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Leukemia, Prolymphocytic, T-Cell; Middle Aged; Neoplasms, Second Primary; Vidarabine | 2012 |
Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
Topics: 2-Chloroadenosine; Anemia; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Deoxyadenosines; Fatal Outcome; Female; Humans; Immunophenotyping; Leukemia, Prolymphocytic; Leukemia, Prolymphocytic, T-Cell; Male; Methotrexate; Middle Aged; Neoplastic Stem Cells; Prednisone; Salvage Therapy; Vidarabine; Vincristine; Zidovudine | 1994 |